Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0253
-0.0047 (-15.67%)
Mar 31, 2025, 3:01 PM EST

Syros Pharmaceuticals Statistics

Total Valuation

SYRS has a market cap or net worth of 804,974. The enterprise value is 2.76 million.

Market Cap 804,974
Enterprise Value 2.76M

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date Mar 21, 2025
Ex-Dividend Date n/a

Share Statistics

SYRS has 26.83 million shares outstanding. The number of shares has increased by 31.77% in one year.

Current Share Class n/a
Shares Outstanding 26.83M
Shares Change (YoY) +31.77%
Shares Change (QoQ) +0.17%
Owned by Insiders (%) 0.58%
Owned by Institutions (%) 11.23%
Float 23.93M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.86
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.03
EV / Sales 7.14
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -0.03

Financial Position

The company has a current ratio of 2.25

Current Ratio 2.25
Quick Ratio 2.05
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -0.60
Interest Coverage -20.92

Financial Efficiency

Return on equity (ROE) is -776.96% and return on invested capital (ROIC) is -94.28%.

Return on Equity (ROE) -776.96%
Return on Assets (ROA) -59.88%
Return on Invested Capital (ROIC) -94.28%
Return on Capital Employed (ROCE) -197.02%
Revenue Per Employee 5,676
Profits Per Employee -1.44M
Employee Count 68
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -99.53% in the last 52 weeks. The beta is 1.31, so SYRS's price volatility has been higher than the market average.

Beta (5Y) 1.31
52-Week Price Change -99.53%
50-Day Moving Average 0.14
200-Day Moving Average 1.92
Relative Strength Index (RSI) 30.76
Average Volume (20 Days) 66,342,156

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.18

Income Statement

In the last 12 months, SYRS had revenue of 386,000 and -97.82 million in losses. Loss per share was -2.66.

Revenue 386,000
Gross Profit -88.25M
Operating Income -111.52M
Pretax Income -97.82M
Net Income -97.82M
EBITDA -110.18M
EBIT -111.52M
Loss Per Share -2.66
Full Income Statement

Balance Sheet

The company has 58.28 million in cash and 60.23 million in debt, giving a net cash position of -1.95 million or -0.07 per share.

Cash & Cash Equivalents 58.28M
Total Debt 60.23M
Net Cash -1.95M
Net Cash Per Share -0.07
Equity (Book Value) -11.12M
Book Value Per Share -0.41
Working Capital 35.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -100.02 million and capital expenditures -38,000, giving a free cash flow of -100.05 million.

Operating Cash Flow -100.02M
Capital Expenditures -38,000
Free Cash Flow -100.05M
FCF Per Share -3.73
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -28,891.71%
Pretax Margin -25,340.67%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SYRS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -31.77%
Shareholder Yield -31.77%
Earnings Yield -12,151.32%
FCF Yield -12,429.47%

Stock Splits

The last stock split was on September 19, 2022. It was a reverse split with a ratio of 0.1.

Last Split Date Sep 19, 2022
Split Type Reverse
Split Ratio 0.1

Scores

SYRS has an Altman Z-Score of -15.52. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -15.52
Piotroski F-Score n/a